All Comments by

  1. Hiroshi Mori on Cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic mice.
  2. Paul Coleman on Sulcal variability in the Alzheimer's brain: correlations with cognition.
  3. John Hardy on Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.
  4. Elliott Mufson on Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells.
  5. Gerry Fischbach on Expression of CD43 in human microglia and its downregulation in Alzheimer's disease.
  6. Paul Coleman on Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer's disease.
  7. Paul Coleman on A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.
  8. John Hardy on Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect.
  9. Hiroshi Mori on Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy.
  10. Paul Coleman on Short-term administration of selegiline for mild-to-moderate dementia of the Alzheimer's type.
  11. Paul Coleman on Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain.
  12. Paul Coleman on Elevation of cerebral proteases after systemic administration of aluminum.
  13. Elliott Mufson on Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
  14. Benjamin Wolozin on Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.
  15. Hiroshi Mori on Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I).